The Trump Administration has effectively ended the Biden Administration's attempt to regulate lab-developed tests,” TD Cowen ...

The startup received de novo authorization for the AI tool, the first of its kind that analyzes mammogram images to predict ...

Nvidia, which is already working with J&J and Medtronic, plans to partner with medtech companies to build platforms for ...

The company also shared more details of its exit from the TAVR market and the impact of FDA layoffs on product review times.

IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of ...

Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory ...

The Court of International Trade said the president overstepped his authority, halting various duties. After an appeal, the ...

The maker of patient monitoring devices said the incident will not have a material effect on its updated financial outlook.

The company will compete with a device Boston Scientific acquired for $850 million.

Speaker Mike Johnson negotiated a number of last minute changes to the megabill to get it across the finish line, including ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...